This peptide does not act as a stimulant for growth hormone or promote its release in the body
Gut-focused patients often feel a calming effect sooner, within the first 2 to 4 weeks
AOD 9604 peptide, also called the fat-burning peptide, is an anti-obesity drug (AOD) that can also be used for losing weight for non-obese patients
For example, you may hear about a 2025 pilot study (considered preliminary research), which found that BPC-157 infusions were well-tolerated with no side effects
Summary: AOD 9604 and retatrutide are both unlicensed investigational compounds in the UK, and there is no clinical evidence or regulatory guidance supporting their combined use
Importantly, AOD-9604 does not bind to growth hormone receptors, which is why it lacks the glucose-elevating and IGF-1-stimulating effects of full-length growth hormone